Exact Mass: 385.0499156
Exact Mass Matches: 385.0499156
Found 106 metabolites which its exact mass value is equals to given mass value 385.0499156,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cefaclor hydrate
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate
(-)-Epigallocatechin sulfate
Epigallocatechin sulfate is the sulfated form of epigallocatechin, wherein the sulfate group is attached to the O-3 position. Sulfation is a phase II biotransformation reaction that involves a sulfotransferase enzyme catalyzing the transfer of a sulfo group from a donor cosubstrate, usually 3-phosphoadenosine-5-phosphosulfate (PAPS), to a substrate molecules hydroxyl group (in this case epigallogatechin). Sulfation is involved in a variety of biological processes, including detoxification, hormone regulation, molecular recognition, cell signaling, and viral entry into cells. Epigallocatechin (EGC) is a flavan-3-ol, which are derivatives of flavans that possess a 2-phenyl-3,4-dihydro-2H-chromen-3-ol skeleton. EGC is one of the antioxidant chemicals found in many fruits and teas. This compound possesses an epimer, found notably in green tea, called "gallocatechin" (GC) (PMID: 30917581), with the gallate residue being in an isomeric trans position. Other sources of gallocatechin are bananas, persimmon, and pomegranate. This compound had been shown to have moderate affinity to the human cannabinoid receptor, which may contribute to the health benefits found by consuming green tea.
Hydroxylansoprazole
C16H14F3N3O3S (385.0707930000001)
Hydroxylansoprazole is only found in individuals that have used or taken Lansoprazole. Hydroxylansoprazole is a metabolite of Lansoprazole. Hydroxylansoprazole belongs to the family of Sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety.
Lansoprazole sulfone
C16H14F3N3O3S (385.0707930000001)
Lansoprazole sulfone is only found in individuals that have used or taken Lansoprazole. Lansoprazole sulfone is a metabolite of Lansoprazole. Lansoprazole sulfone belongs to the family of Sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety.
Alizarin complexone
Mavacoxib
C16H11F4N3O2S (385.05080740000005)
3-[4-Methoxy-2-(trifluoromethyl)-6-quinolyl]prop-2-ynyl benzoate
(1R+,5S+,6S*)-6,1h-Dichlor-5-hydroxy-9,3(1h)-axinyssadien-15-yl-carbonimid-dichlorid|axinyssane
anisodamine
C17H24BrNO4 (385.08886040000004)
Anisodamine hydrobromide (6-Hydroxyhyoscyamine hydrobromide), a belladonna alkaloid, is a non-subtype-selective muscarinic and a nicotinic cholinoceptor antagonist. Anisodamine hydrobromide shows antioxidant, anti-inflammatory properties[1][2]. Anisodamine hydrobromide (6-Hydroxyhyoscyamine hydrobromide), a belladonna alkaloid, is a non-subtype-selective muscarinic and a nicotinic cholinoceptor antagonist. Anisodamine hydrobromide shows antioxidant, anti-inflammatory properties[1][2].
Azasetron HCl
C17H21Cl2N3O3 (385.09598960000005)
Azasetron (Y-25130) hydrochloride, a benzamide derivative, is a potent and selective 5-HT3 receptor antagonist. Azasetron is used in the study for Chemotherapy-induced nausea and vomiting (CINV)[1].
OXODIPEROXY(PYRIDINE)(1,3-DIMETHYL-3,4,5,6-TETRAHYDRO-2(1H)-PYRIMIDINONE)MOLYBDENUM (IV)
C11H17MoN3O6 (385.01713520000004)
Methyl (2S)-(2-chlorophenyl){[(4-nitrophenyl)sulfonyl]oxy}acetate
C15H12ClNO7S (385.00229920000004)
2,2,3-tris(4-chlorophenyl)propiononitrile
C21H14Cl3N (385.01917740000005)
6-BROMO-2-(3-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID
Thiazolidine, 2-(4-methoxyphenyl)-3-(1-naphthalenylsulfonyl)- (9CI)
C20H19NO3S2 (385.0806304000001)
6-BROMO-2-(2-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID
6-BROMO-2-(4-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID
2,3-dimethylnaphtho[1,2-d]thiazolium tosylate
C20H19NO3S2 (385.0806304000001)
tert-butyl 4-(4-bromo-2-methoxyphenoxy)piperidine-1-carboxylate
C17H24BrNO4 (385.08886040000004)
Bis(ethylenediamine)platinum(II) chloride
C4H16Cl2N4Pt (385.03998060000004)
ethyl 2-piperazine-4-(3,5-dichloro)phenyl thiazole-5-carboxylate
C16H17Cl2N3O2S (385.04184820000006)
METHYL 2-(2,4-DICHLORO-5-FLUOROBENZOYL)-3-((4-FLUOROPHENYL)AMINO)ACRYLATE
C17H11Cl2F2NO3 (385.00840200000005)
[7-(2-nitrooxyethoxy)-4-oxo-2-phenylchromen-5-yl] acetate
tert-butyl N-[4-(bromomethyl)phenyl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate
C17H24BrNO4 (385.08886040000004)
5-bromo-6-chloro-3-indoxyl nonanoate
C17H21BrClNO2 (385.04440960000005)
AMMONIUM PENTABORATE TETRAHYDRATE
B5H12NO19-------------- (385.04687920000003)
YS-49
C20H20BrNO2 (385.06773200000003)
YS-49 is a PI3K/Akt (a downstream target of RhoA) activator, to reduce RhoA/PTEN activation in the 3-methylcholanthrene-treated cells. YS-49 inhibits angiotensin II (Ang II)-stimulated proliferation of VSMCs via induction of heme oxygenase (HO)-1. YS-49 is also an isoquinoline compound alkaloid, has a strong positive inotropic action through activation of cardiac β-adrenoceptors[1][2][3]. YS-49 is a PI3K/Akt (a downstream target of RhoA) activator, to reduce RhoA/PTEN activation in the 3-methylcholanthrene-treated cells. YS-49 inhibits angiotensin II (Ang II)-stimulated proliferation of VSMCs via induction of heme oxygenase (HO)-1. YS-49 is also an isoquinoline compound alkaloid, has a strong positive inotropic action through activation of cardiac β-adrenoceptors[1][2][3].
N-{3-Chloro-4-[(2-chlorobenzoyl)amino]phenyl}-2-pyridinecarboxami de
2-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]-1,3-thiazole-5-carboxylic acid
C16H14F3N3O3S (385.0707930000001)
Arsonic acid,[4-[[4-(dimethylamino)phenyl]azo]phenyl]-, monohydrochloride (9CI)
(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol
(Z)-methyl 1-(2-chloroacetyl)-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate
C20H16ClNO5 (385.07169560000006)
Azasetron
C17H20ClN3O3·HCl (385.09598960000005)
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Azasetron (Y-25130) hydrochloride, a benzamide derivative, is a potent and selective 5-HT3 receptor antagonist. Azasetron is used in the study for Chemotherapy-induced nausea and vomiting (CINV)[1].
ethyl 8-cyano-2-((4-fluorophenylthio)Methyl)-7-MethoxyiMidazo[1,2-a]pyridine-3-carboxylate
(5-bromo-4-chloro-1H-indol-3-yl) nonanoate
C17H21BrClNO2 (385.04440960000005)
4-(4-Bromo-1H-pyrazol-1-yl)-N,N-diisopropylbenzenesulfonamide
C15H20BrN3O2S (385.04595200000006)
tert-butyl 4-(4-bromo-2-fluorobenzoyl)piperidine-1-carboxylate
Mavacoxib
C16H11F4N3O2S (385.05080740000005)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor
(3-Chlorophenyl)-[4-(7-chloro-4-quinolinyl)-1-piperazinyl]methanone
5-[1-(4-Fluorophenyl)sulfonyl-3-pyrazolyl]-2-phenylthiazole
(4-Chlorophenyl)-[4-(7-chloro-4-quinolinyl)-1-piperazinyl]methanone
ethyl 1-[4-(2-fluorophenyl)-1,3-thiazol-2-yl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate
C16H11F4N3O2S (385.05080740000005)
Ethyl 5-[(2-chlorophenyl)sulfanyl]-3-(4-methylphenyl)-1,2,4-triazine-6-carboxylate
C19H16ClN3O2S (385.06517060000004)
2-[[oxo-(1-oxo-3,4-dihydro-1H-2-benzopyran-3-yl)methyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester
C20H19NO5S (385.0983884000001)
2-[(4-fluorophenyl)sulfonyl-(2-pyridinyl)amino]-N-phenylacetamide
2-chloro-4-fluoro-N-[4-methoxy-3-(4-methoxyphenyl)phenyl]benzamide
C21H17ClFNO3 (385.08809340000005)
n-Ethyl-n-[(nonafluorobutyl)sulfonyl]glycine
C8H8F9NO4S (385.00303160000004)
[(2R,3S,4R,5S)-5-{2-amino-5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl}-3,4-dihydroxyoxolan-2-yl]methyl phosphate
(2S,4E)-4-[2-[(1S)-1-carboxylato-2-(3,4-dioxocyclohexa-1,5-dien-1-yl)ethyl]iminoethylidene]-2,3-dihydro-1H-pyridine-2,6-dicarboxylate
(4aR)-1,4a,8,10,11-pentahydroxy-3,12-dioxo-5,12a-dihydro-4H-tetracene-2-carboxamide
N-[4-oxo-5-(2-oxo-1H-indol-3-ylidene)-2-thiazolyl]benzenesulfonamide
(1R,3S)-3-(4-iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylic acid methyl ester
Benzylidenehydrazine derivative, 12
C15H20BrN3O4 (385.06371000000007)
(5E)-5-{[5-(1H-benzimidazol-2-ylthio)-2-furyl]methylene}-3-isopropyl-1,3-thiazolidine-2,4-dione
C18H15N3O3S2 (385.05548000000005)
2,5-dimethoxy-N-(4-phenoxyphenyl)benzenesulfonamide
C20H19NO5S (385.0983884000001)
Versicolorone(1-)
An organic anion that is the conjugate base of versicolorone, obtained by selective deprotonation of the 2-hydroxy group.
(2S)-versicolorone(1-)
An organic anion obtained by selective deprotonation of the 2-hydroxy group of (2S)-versicolorone.
3-chloro-N-[3-nitro-5-(2-pyridinylthio)phenyl]benzamide
4-chloro-3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide
C15H16ClN3O3S2 (385.03215759999995)
(S)-5-oxoaverantin(1-)
A phenolate anion obtained by deprotonation of the 2-hydroxy group of (S)-5-oxoaverantin. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
N-(4-bromo-5-methyl-2-oxo-3-indolyl)-3-phenylpropanehydrazide
N-[4-bromo-3-(trifluoromethyl)phenyl]-2,4,6-trimethylbenzamide
C17H15BrF3NO (385.02890360000004)
4-(3-hydroxyphenyl)-1-(thiophen-2-ylmethyl)-4H-pyridine-3,5-dicarboxylic acid dimethyl ester
C20H19NO5S (385.0983884000001)
1-[1-[(2-Chloro-6-fluorophenyl)methyl]-2-oxo-3-pyridinyl]-3-(phenylmethyl)urea
1-(4-oxo-2-thieno[3,2-d][1,3]thiazinyl)-N-(phenylmethyl)-3-piperidinecarboxamide
C19H19N3O2S2 (385.09186339999997)
3-(4-chlorophenyl)-1-methyl-N-[(5-methyl-2-furanyl)methyl]-5-thieno[2,3-c]pyrazolecarboxamide
C19H16ClN3O2S (385.06517060000004)
[4-[(Z)-2-cyano-2-(6-methyl-1H-benzimidazol-2-yl)ethenyl]phenyl] thiophene-2-carboxylate
N-[(2-chlorophenyl)-oxomethyl]-1-ethyl-4-hydroxy-2-oxo-3-quinolinecarbohydrazide
C19H16ClN3O4 (385.08292860000006)
[5-(2-amino-5-carbamimidoyl-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl hydrogen phosphate
[5-[2-amino-5-(methylaminomethyl)-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl]-3-hydroxy-2,5-dihydrofuran-2-yl]methyl phosphate
GLUT4-IN-2
GLUT4-IN-2 is a potent and selective GLUT4 inhibitor with IC50s of 11.4 μM and 6.8 μM for GLUT1 and GLUT4, respectively. GLUT4-IN-2 induces cell apoptosis and cell cycle arrest at G0/G1phase. GLUT4-IN-2 shows potent antitumor activity[1].
aristolochicacid iva methyl ester
{"Ingredient_id": "HBIN016810","Ingredient_name": "aristolochicacid iva methyl ester","Alias": "NA","Ingredient_formula": "C19H15NO8","Ingredient_Smile": "COC1=CC2=C3C(=C(C=C2C(=C1)OC)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1720","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-({3-[(4-hydroxyphenyl)methanethioamido]-1-sulfanylpropylidene}amino)-n-(3-hydroxypropyl)propanimidothioic acid
3-(3-bromo-4-hydroxyphenyl)-n-(4-carbamimidamidobutyl)-2-(n-hydroxyimino)propanamide
C14H20BrN5O3 (385.0749430000001)
1-chloro-n-{2-chloro-2-[4-chloro-5-hydroxy-3-methyl-3-(4-methylpent-3-en-1-yl)cyclohexylidene]ethyl}methanecarbonimidoyl chloride
(2e)-3-(3-bromo-4-hydroxyphenyl)-n-(4-carbamimidamidobutyl)-2-(n-hydroxyimino)propanimidic acid
C14H20BrN5O3 (385.0749430000001)